 The Covid-19 pandemic has caused widespread concern over the potential for a global pandemic. As such, there is a need for an effective treatment to reduce the spread of the virus and prevent further deaths. Chloroquine and hydroxychloroquine have been used to treat severe pneumonia associated with Covid-19, but their efficacy remains unclear due to a lack of randomized control trials and misinterpretation of clinical evidence. This paper reviews the current evidence on the use of these drugs and highlights the risks of using them without proper medical supervision. Given the limited evidence, it is recommended that the use of chloroquine or hydroxychloroquine should only be initiated by specialists treating Covid-19 patients under close cardiac monitoring. This article was authored by Syed Shahzad Hassan, Qiyasi Angkau and Hamid A. Merchant.